Chime Biologics
Chime Biologics
Revolutionary Model Predicts Biologic Processing Variations
BIOT
🔍 Scientists have developed a mathematical model to predict RTD in continuous manufacturing of biologics. 🔬🔬🧪💯🔬
MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom
BIOT
📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬
Game-Changing Cancer Immunotherapy Deal Unveiled
BIOT
📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝
